On the Move: Who's Going Where in Biopharma and Medtech Start-Ups (01/2010)
This article was originally published in Start Up
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
You may also be interested in...
Executives On The Move: Global Aesthetics Head Exits Allergan for Merz, C-Level Commercial Changes at Flexion And Karyopharm
Merz Pharma Group’s Merz Aesthetics welcomes former Allergan exec as new chief scientific officer. Meanwhile, a chief commercial officer is appointed at Flexion Therapeutics, developer of treatments for musculoskeletal conditions, and at Karyopharm Therapeutics, an oncology-focused pharma.
Executives On The Move: UCB Announces Future Financial Leadership Change And Analytics Experience for Corbus Pharma
Corbus Pharmaceuticals, developer of therapeutics for inflammatory and fibrotic diseases, hires EMD Serono exec as head of commercial ops and analytics. Also, multinational biopharma UCB to have a new CFO in July.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.